Try our mobile app

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
Website: thermofisher.com


  • Pretty weak financial results growth rate 6.4% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-0.2%)
  • Dividend yield for the last twelve months 0.3%
  • Free cash flow yield -1.3% (LTM)
  • Share price is 14.4% higher than minimum and 20.9% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (20.1x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $33.8 mln (-0.016% of cap.)

Key Financials (Download financials)

Ticker: TMO
Share price, USD:  (-0.8%)493.55
year average price 563.48  


year start price 571.56 2024-04-02

max close price 624.21 2024-09-10

min close price 497.60 2025-03-31

current price 493.55 2025-04-01
Common stocks: 391 000 000

Dividend Yield:  0.3%
FCF Yield LTM: -1.3%
EV / LTM EBITDA: 20.1x
EV / EBITDA annualized: 20.5x
Last revenue growth (y/y):  +4.7%
Last growth of EBITDA (y/y):  +8.2%
Historical revenue growth:  +3.4%
Historical growth of EBITDA:  -3.7%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 192 978
Net Debt ($m): -5 480
EV (Enterprise Value): 187 498
EBITDA LTM ($m): 9 325
EV / LTM EBITDA: 20.1x
Price to Book: 4.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-03-28globenewswire.com

Biohazard Bags Report 2025-2030 Featuring Thermo Fisher Scientific, Bel-Art, International Plastics, Cole-Parmer, Medegen, Tufpak, Capitol Scientific, Abdos Life Science, Tilak Polypack, Desco Medical

2025-03-20zacks.com

TMO Stock Set to Gain From the Launch of New Vulcan Automated Lab

2025-03-06seekingalpha.com

Thermo Fisher Scientific: Strong Q4, Strategic M&A, And Poised For Growth In Life Sciences

2025-02-13zacks.com

TMO Stock Set to Gain From The Launch of New Spatial Imaging System

2025-02-12globenewswire.com

Laboratory Supplies Market Analysis 2022-2024 and Forecast 2025-2030, Featuring Profiles of Key Players - Th. Geyer, Thermo Fisher, Spectrum Chemical Manufacturing Corp., Ing.

2025-01-31seekingalpha.com

Thermo Fisher Scientific: Finally Ready For A Breakout? (Upgrade)

2025-01-30investopedia.com

Thermo Fisher Stock Surges as Medical Device Maker's Results Top Estimates

2025-01-30zacks.com

Thermo Fisher Q4 Earnings and Revenues Top Estimates, Stock Up

2025-01-30seekingalpha.com

Thermo Fisher Scientific Inc. (TMO) Q4 2024 Earnings Call Transcript

2025-01-30zacks.com

Thermo Fisher Scientific (TMO) Q4 Earnings and Revenues Top Estimates
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data